Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Age and new weight-loss drugs
Age and the new weight-loss drugs
Are you wondering whether you’re a candidate for one of the newer weight-loss drugs, semaglutide (Wegovy) and tirzepatide (Zepbound)? These injectables are approved specifically for weight loss in adults who are overweight or have obesity plus at least one of these conditions: high blood pressure,
Weight-Loss Drugs Saved Me From Alcoholism
Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating alcoholism and other addictions?
Obesity rates are down. Is that because of weight-loss drugs?
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.
Opinion
Biden Decision on Weight-Loss Drugs a Push-Back on Progressives
Last week, the Biden administration passed a rule allowing for the government healthcare programs Medicare and Medicaid coverage of a class of
Why your co-pay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Prices on weight loss drugs are dropping — What patients need to know
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr. Faith Coleman explains.
Are Weight-Loss Drugs Contributing to a Fall in the Obesity Rate?
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
Why the New Weight Loss Drugs Don't Work for Some People
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone. In tho
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.
14h
‘Lifting from head to toe’: Weight-loss drugs boost popularity of surgeries to remove extra skin
Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...
6d
Weight-loss drugs deliver life-changing health benefits - and big profits
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Berkshire Eagle
9h
Weight loss medications are effective but expensive. What will the future hold?
They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...
Rolling Out
4d
Weight loss drugs challenge pregnancy planning for women
This allows the body time to adjust and stabilize. Maternal health management:
Weight
loss
drugs
can have different ...
2d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
3d
New weight loss pharmacy opens in Marquette Township
The licensed pharmacy carries compounded Semaglutide and Tirzepatide, both of which are active ingredients in Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Biden
Ozempic
Eli Lilly
Zepbound
Wegovy
Feedback